National Marrow Donor Program

City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Retrieved on: 
Donnerstag, Mai 23, 2024
Research, Hospitals, Clinical Trials, Telemedicine, Virtual Medicine, Stem Cells, Biotechnology, Pharmaceutical, Health, Science, Oncology, HLA, Ageing, Blood, Transplant, Medicine, NMDP, Survival, Mantle cell lymphoma, Telephone, Constipation, Lymphoma, Neoplasm, Graft-versus-host disease, Happiness, B cell, Physician, Subduction, Pathology, Anemia, Education, Social work, Clinical trial, Hospital, Comfort, Patient, Student, ASCO, GVHD, Occupational therapy, Environment, City, Haematopoietic system, National Marrow Donor Program, Progression-free survival, Bone marrow, TeleVideo, Fatigue, Abstract, Pharmacy, Quality of life, Nursing

City of Hope has performed over 19,000 transplants, is one of the nation’s leading transplant programs and is at the forefront of using transplants to treat older adults with blood cancers.

Key Points: 
  • City of Hope has performed over 19,000 transplants, is one of the nation’s leading transplant programs and is at the forefront of using transplants to treat older adults with blood cancers.
  • The adult cohorts of this trial recruitment have closed with more than 200 patients in follow-up.
  • Kennedy Geriatric Oncology Award, which honors geriatric oncologists who have demonstrated outstanding leadership and achievement in the field of geriatric oncology.
  • Presenter: Richard T. Lee , M.D., City of Hope clinical professor, Supportive and Integrative Medicine Program; Cherng Family Director's Chair for the Center for Integrative Oncology
    Presenter: Daniel Schmolze , M.D., City of Hope associate clinical professor, Department of Pathology

Medical College of Wisconsin Cancer Center leads groundbreaking change in Medicare policy for MDS patients over 65 in need of lifesaving transplants

Retrieved on: 
Mittwoch, Mai 8, 2024
BMT, NMDP, Transplant, MCW, National Marrow Donor Program, MD, HCT, Research, Doctor of Science, History, Syndrome, ASH, Patient, Society, Medicare, Blood, MDS, Cancer, Medical college

MDS is a group of cancers that affect the body's ability to produce healthy blood cells.

Key Points: 
  • MDS is a group of cancers that affect the body's ability to produce healthy blood cells.
  • Allogeneic HCT is the only curative therapy for patients with MDS.
  • This challenge was further exacerbated since older adults were, consequently, overlooked as candidates for transplant because they did not have Medicare coverage for the procedure.
  • A final decision was recently made by Medicare in the form of a National Coverage Analysis Decision Memo to expand Medicare coverage for the affected population.

Be The Match® Affirms Global Leadership in Life-saving Cell Therapies with New Name, Brand: NMDP℠

Retrieved on: 
Montag, Januar 8, 2024
NMDP, Marketing, Senior counsel, Ecosystem, Sickle cell disease, University, Physician, National Marrow Donor Program, Student, Research, Bone marrow, HLA, Long Way, MD, Society, Insurance, Volunteering, GVHD, Patient, All, Hematology, Disorder, Pharmaceutical industry

Over nearly four decades, the world has evolved, and so have we, expanding our global footprint, advancing research throughout the cell therapy ecosystem and impacting more people’s lives,” said Amy Ronneberg, CEO, NMDP.

Key Points: 
  • Over nearly four decades, the world has evolved, and so have we, expanding our global footprint, advancing research throughout the cell therapy ecosystem and impacting more people’s lives,” said Amy Ronneberg, CEO, NMDP.
  • Research advancements are driving the organization’s growth in enabling more patients than ever before to access cell therapy – a record 7,435 lives in 2023.
  • “These findings have helped more patients from a diverse range of ethnic backgrounds receive critical cell therapy.
  • Together, NMDP and its network strive to create a world where every patient can receive their life-saving cell therapy.

Be The Match Announces Winners of 2023 NMDP/Be The Match Awards

Retrieved on: 
Montag, November 27, 2023
NMDP, Stanford University, Caregiver, National Marrow Donor Program, Research, Leukemia, HLA, Minnie Pearl, Congress, Cancer, GVHD, Stanford University Medical Center, Patient, Diagnosis, Organization, SHC, Bone marrow, Immune disorder, AML, Dentistry

MINNEAPOLIS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match®, today announced the recipients of its annual NMDP/Be The Match Awards at The ONE Forum 2023.

Key Points: 
  • MINNEAPOLIS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match®, today announced the recipients of its annual NMDP/Be The Match Awards at The ONE Forum 2023.
  • The awards honor individuals, groups, NMDP/Be The Match Network members or organizations working to increase awareness or access to potentially life-saving cell therapy.
  • The 2023 NMDP/Be The Match Award recipients are:
    Dr. Mukherjee’s idea for a new approach to cancer treatment led to groundbreaking research that has the potential to transform outcomes for patients with AML and other blood cancers.
  • “We are honored to celebrate and acknowledge the contributions of this year’s NMDP/Be The Match Award winners,” said Amy Ronneberg, Chief Executive Officer for NMDP/Be The Match.

Be The Match Raises $1.1 Million at Annual Gala

Retrieved on: 
Donnerstag, Oktober 5, 2023
National Marrow Donor Program, WCCO (AM), Ioan, Patient, Love, EPlus, Bone marrow, Leukemia, Science, Research, NMDP, Dentistry, Match

These funds go directly to providing patient assistance grants, pioneering research in the transplant field, and expanding the diversity of the Be The Match Registry®.

Key Points: 
  • These funds go directly to providing patient assistance grants, pioneering research in the transplant field, and expanding the diversity of the Be The Match Registry®.
  • In 2022, Be The Match Foundation provided $6.1 million in grants to 2,320 patients and their families in need of financial assistance.
  • Ever since experiencing the impact of Be The Match, the Furlong Family continues to be steadfast supporters.
  • When you think about what Be The Match stands for - it is the perfect intersection of science and love.

Ossium Health to Present at Cell & Gene Meeting on the Mesa

Retrieved on: 
Montag, Oktober 9, 2023
Oncology, Health, Clinical Trials, Research, Science, Biotechnology, Trial of the century, Regenerative medicine, Cell, Mesa, Safety, National Marrow Donor Program, Tissue engineering, Gene editing, Bone marrow, Patient, NMDP, Pharmaceutical industry

Ossium Health announced today that Kevin Caldwell, CEO, Co-Founder & President, will present at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California and live streamed globally.

Key Points: 
  • Ossium Health announced today that Kevin Caldwell, CEO, Co-Founder & President, will present at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California and live streamed globally.
  • Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference featuring more than 120 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies, as well as over 100 panelists and featured speakers.
  • Kevin will provide attendees with a first glimpse inside Ossium’s landmark clinical study recently launched in collaboration with the National Marrow Donor Program® (NMDP) / Be The Match®.
  • The following are specific details regarding Ossium Health’s presentation at the conference:
    Virtual attendance is available which includes a livestream of Ossium Health’s presentation and the ability to view all conference sessions on-demand.

Edward Owusu Kwarteng, Ph.D., BSc, MSc, Honored With The 2023 ASH-CIBMTR-ASTCT Career Development Award

Retrieved on: 
Montag, Oktober 2, 2023
University of Texas Southwestern Medical Center, National Marrow Donor Program, University, MCW, ASH, Senior, Virology, Medical college, Exposition, Transplant, Cell, Stem cell, Bachelor of Science, Health, University of Cape Coast, Glycolysis, Metabolism, MD, Patient, NMDP, Master of Science, Diversity, Medical College of Wisconsin, Inclusion, INRS, B cell, Society, Synthetic biology, Hematopoietic stem cell transplantation, Nursing, Hematology, Research

This award is exclusively for clinical and translational researchers who plan to practice hematopoietic stem cell transplantation and cellular therapy clinical patient care.

Key Points: 
  • This award is exclusively for clinical and translational researchers who plan to practice hematopoietic stem cell transplantation and cellular therapy clinical patient care.
  • The CIBMTR is a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW).
  • The award is part of a program to increase racial and ethnic diversity in the next generation of medical professionals.
  • Dr. Kwarteng receives registration for the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.

National Marrow Donor Program® (NMDP)/Be The Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access To Transplant

Retrieved on: 
Dienstag, September 26, 2023
Health, National Marrow Donor Program, Partnership, Biobank, Bone marrow, Cell, PBSC, Stem cell, Cryopreservation, Patient, Physician, NMDP, Haematopoietic system, Dentistry, Match

These new collaborations add industry-leading expertise in cryopreservation and storage of hematopoietic stem cells and will increase donor availability.

Key Points: 
  • These new collaborations add industry-leading expertise in cryopreservation and storage of hematopoietic stem cells and will increase donor availability.
  • The NMDP cryopreservation service is available to any transplant center in the NMDP/Be The Match network.
  • This process increases flexibility for the donor and the ability of a patient to secure a cell source.
  • This partnership will build on Comprehensive Cell Solutions’ mission to change lives, one patient at a time.”
    For more information on NMDP cryopreservation service, visit their website .

GVHD Alliance Commemorates Blood Cancer Awareness Month: Welcomes The Leukemia & Lymphoma Society, Announces Meredith A. Cowden Patient Advocacy Achievement Award

Retrieved on: 
Dienstag, September 12, 2023
Graft-versus-host disease, National Marrow Donor Program, Meredith, Education, RYE, Integration, Quality of life, Cell, BMT, LLS, Organization, Cowden, Leukemia & Lymphoma Society, Patient, NMDP, Transplant, Match, Sanofi, Leukemia, Society, Support, Dentistry, Nursing, GVHD

The Alliance is also announcing the inaugural Meredith A. Cowden Patient Advocacy Achievement Award, honoring a member of the GVHD community who is making a profound difference in the lives of GVHD patients.

Key Points: 
  • The Alliance is also announcing the inaugural Meredith A. Cowden Patient Advocacy Achievement Award, honoring a member of the GVHD community who is making a profound difference in the lives of GVHD patients.
  • GVHD is a rare disease that commonly impacts allogeneic blood and marrow transplant recipients, meaning the cells came from a donor.
  • The Meredith A. Cowden Patient Advocacy Achievement Award will be presented on October 13, 2023, during the Meredith A. Cowden Foundation's GVHD Symposium in Independence, Ohio.
  • I am humbled to be recognized in such a meaningful way," said Meredith Cowden of the Meredith A. Cowden Foundation.

Ossium Health® and Be The Match® Unveil Partnership to Increase Bone Marrow Transplant Accessibility and Treatment Efficiency

Retrieved on: 
Donnerstag, August 31, 2023
Stem Cells, Biotechnology, Other Health, Health, General Health, Oncology, Other Science, Research, Surgery, Science, Clinical Trials, National Marrow Donor Program, Partnership, NMDP, Clinical trial, Bone marrow, AP, Multimedia, Cell, Organization, Patient, Transplant, Safety, Dentistry, Match

View the full release here: https://www.businesswire.com/news/home/20230831050319/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230831050319/en/
    Ossium and NMDP/Be The Match are kicking off a clinical trial to demonstrate the safety and efficacy of Ossium’s bone marrow product.
  • PRESERVE I “A First-in-Human Study of HLA-Partially to Fully Matched Allogeneic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies” ( NCT05589896 ) is anticipated to open in Q4 2023.
  • With favorable trial results, the two organizations will then work to integrate the bone marrow donations in Ossium Health's proprietary bank into NMDP/Be The Match's national donor registry.
  • This partnership will dramatically increase Ossium’s ability to serve patients at scale, and allow NMDP/Be The Match to offer a new source of life-saving bone marrow to a wider group of patients in need.